Ana De Jesus-Acosta
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University · Sidney Kimmel Comprehensive Cancer Center JHMI
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ana De Jesus-Acosta as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:16 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03638141 · CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and TremelimumabSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Intermediate Stage of Hepatocellular Carcinoma, Hepatocellular Carcinoma · principal investigator
- Ph2NCT02452970 · RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line TherapyEpicentRx, Inc. · terminated · Cholangiocarcinoma
- Ph2NCT02451982 · Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the PancreasSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · active not recruiting · Pancreatic Cancer · principal investigator
- Ph1/Ph2NCT01431794 · Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic AdenocarcinomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Pancreatic Ductal Adenocarcinoma · principal investigator
- Ph2NCT01088815 · Hedgehog Inhibitors for Metastatic Adenocarcinoma of the PancreasSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Metastatic Pancreatic Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:16 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical TrialR01CA197296 · NCI · JOHNS HOPKINS UNIVERSITY · PI William Reece Burns, Eric Christenson, ELIZABETH M. JAFFEE · fiscal years 2015 to 2026Named on NCT02451982
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.